1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Meningococcal Vaccine Consumption 2016-2026

2.1.2 Meningococcal Vaccine Consumption CAGR by Region

2.2 Meningococcal Vaccine Segment by Type

2.2.1 Quadrivalent

2.2.2 Bivalent

2.2.3 Others

2.3 Meningococcal Vaccine Sales by Type

2.3.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Meningococcal Vaccine Sale Price by Type (2016-2021)

2.4 Meningococcal Vaccine Segment by Application

2.4.1 Pneumonia

2.4.2 Meningitis

2.4.3 Bacteremia

2.4.4 Others (Arthritis, Conjunctivitis, Urethritis)

2.5 Meningococcal Vaccine Sales by Application

2.5.1 Global Meningococcal Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Meningococcal Vaccine Sale Price by Application (2016-2021)

3 Global Meningococcal Vaccine by Company

3.1 Global Meningococcal Vaccine Sales Market Share by Company

3.1.1 Global Meningococcal Vaccine Sales by Company (2019-2021)

3.1.2 Global Meningococcal Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Meningococcal Vaccine Revenue Market Share by Company

3.2.1 Global Meningococcal Vaccine Revenue by Company (2019-2021)

3.2.2 Global Meningococcal Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Meningococcal Vaccine Sale Price by Company

3.4 Global Manufacturers Meningococcal Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Meningococcal Vaccine Product Location Distribution

3.4.2 Players Meningococcal Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Meningococcal Vaccine by Region

4.1 Global Meningococcal Vaccine by Region

4.1.1 Global Meningococcal Vaccine Sales by Region

4.1.2 Global Meningococcal Vaccine Revenue by Region

4.2 Americas Meningococcal Vaccine Sales Growth

4.3 APAC Meningococcal Vaccine Sales Growth

4.4 Europe Meningococcal Vaccine Sales Growth

4.5 Middle East & Africa Meningococcal Vaccine Sales Growth

5 Americas

5.1 Americas Meningococcal Vaccine Sales by Country

5.1.1 Americas Meningococcal Vaccine Sales by Country (2016-2021)

5.1.2 Americas Meningococcal Vaccine Revenue by Country (2016-2021)

5.2 Americas Meningococcal Vaccine Sales by Type

5.3 Americas Meningococcal Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Meningococcal Vaccine Sales by Region

6.1.1 APAC Meningococcal Vaccine Sales by Region (2016-2021)

6.1.2 APAC Meningococcal Vaccine Revenue by Region (2016-2021)

6.2 APAC Meningococcal Vaccine Sales by Type

6.3 APAC Meningococcal Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Meningococcal Vaccine by Country

7.1.1 Europe Meningococcal Vaccine Sales by Country (2016-2021)

7.1.2 Europe Meningococcal Vaccine Revenue by Country (2016-2021)

7.2 Europe Meningococcal Vaccine Sales by Type

7.3 Europe Meningococcal Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Meningococcal Vaccine by Country

8.1.1 Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Meningococcal Vaccine Sales by Type

8.3 Middle East & Africa Meningococcal Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Meningococcal Vaccine Distributors

10.3 Meningococcal Vaccine Customer

11 Global Meningococcal Vaccine Market Forecast

11.1 Global Meningococcal Vaccine Forecast by Region

11.1.1 Global Meningococcal Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Meningococcal Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Meningococcal Vaccine Forecast by Type

11.7 Global Meningococcal Vaccine Forecast by Application

12 Key Players Analysis

12.1 Novartis

12.1.1 Novartis Novartis Company Information

12.1.2 Novartis Meningococcal Vaccine Product Offered

12.1.3 Novartis Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Novartis Main Business Overview

12.1.5 Novartis Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Meningococcal Vaccine Product Offered

12.2.3 GSK Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Merck

12.3.1 Merck Company Information

12.3.2 Merck Meningococcal Vaccine Product Offered

12.3.3 Merck Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Merck Main Business Overview

12.3.5 Merck Latest Developments

12.4 CSL

12.4.1 CSL Company Information

12.4.2 CSL Meningococcal Vaccine Product Offered

12.4.3 CSL Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 CSL Main Business Overview

12.4.5 CSL Latest Developments

12.5 Baxter

12.5.1 Baxter Company Information

12.5.2 Baxter Meningococcal Vaccine Product Offered

12.5.3 Baxter Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Baxter Main Business Overview

12.5.5 Baxter Latest Developments

12.6 JN International Medical Corporation

12.6.1 JN International Medical Corporation Company Information

12.6.2 JN International Medical Corporation Meningococcal Vaccine Product Offered

12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 JN International Medical Corporation Main Business Overview

12.6.5 JN International Medical Corporation Latest Developments

12.7 Serum Institute of India

12.7.1 Serum Institute of India Company Information

12.7.2 Serum Institute of India Meningococcal Vaccine Product Offered

12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Serum Institute of India Main Business Overview

12.7.5 Serum Institute of India Latest Developments

12.8 Bio-Med

12.8.1 Bio-Med Company Information

12.8.2 Bio-Med Meningococcal Vaccine Product Offered

12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Bio-Med Main Business Overview

12.8.5 Bio-Med Latest Developments

12.9 China National Biotec Group

12.9.1 China National Biotec Group Company Information

12.9.2 China National Biotec Group Meningococcal Vaccine Product Offered

12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 China National Biotec Group Main Business Overview

12.9.5 China National Biotec Group Latest Developments

12.10 Hualan Bio

12.10.1 Hualan Bio Company Information

12.10.2 Hualan Bio Meningococcal Vaccine Product Offered

12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Hualan Bio Main Business Overview

12.10.5 Hualan Bio Latest Developments

12.11 Walvax

12.11.1 Walvax Company Information

12.11.2 Walvax Meningococcal Vaccine Product Offered

12.11.3 Walvax Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Walvax Main Business Overview

12.11.5 Walvax Latest Developments

12.12 Zhifei

12.12.1 Zhifei Company Information

12.12.2 Zhifei Meningococcal Vaccine Product Offered

12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Zhifei Main Business Overview

12.12.5 Zhifei Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Meningococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Quadrivalent

Table 3. Major Players of Bivalent

Table 4. Major Players of Others

Table 5. Global Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)

Table 6. Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)

Table 7. Global Meningococcal Vaccine Revenue by Type (2016-2021) & ($ million)

Table 8. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)

Table 9. Global Meningococcal Vaccine Sale Price by Type (2016-2021)

Table 10. Global Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)

Table 11. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Table 12. Global Meningococcal Vaccine Value by Application (2016-2021)

Table 13. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)

Table 14. Global Meningococcal Vaccine Sale Price by Application (2016-2021)

Table 15. Global Meningococcal Vaccine Sales by Company (2019-2021) & (K Dose)

Table 16. Global Meningococcal Vaccine Sales Market Share by Company (2019-2021)

Table 17. Global Meningococcal Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Meningococcal Vaccine Revenue Market Share by Company (2019-2021)

Table 19. Global Meningococcal Vaccine Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Meningococcal Vaccine Producing Area Distribution and Sales Area

Table 21. Players Meningococcal Vaccine Products Offered

Table 22. Meningococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Meningococcal Vaccine Sales by Region (2016-2021) (K Dose)

Table 26. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)

Table 27. Global Meningococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)

Table 29. Americas Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)

Table 30. Americas Meningococcal Vaccine Sales Market Share by Country (2016-2021)

Table 31. Americas Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Meningococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 33. Americas Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)

Table 34. Americas Meningococcal Vaccine Sales Market Share by Type (2016-2021)

Table 35. Americas Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)

Table 36. Americas Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Table 37. APAC Meningococcal Vaccine Sales by Region (2016-2021) & (K Dose)

Table 38. APAC Meningococcal Vaccine Sales Market Share by Region (2016-2021)

Table 39. APAC Meningococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Meningococcal Vaccine Revenue Market Share by Region (2016-2021)

Table 41. APAC Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)

Table 42. APAC Meningococcal Vaccine Sales Market Share by Type (2016-2021)

Table 43. APAC Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)

Table 44. APAC Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Table 45. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)

Table 46. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)

Table 47. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 49. Europe Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)

Table 50. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2021)

Table 51. Europe Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)

Table 52. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021) & (K Dose)

Table 54. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)

Table 58. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)

Table 60. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Table 61. Global Meningococcal Vaccine Sales Forecast by Type (2021-2026) & (K Dose)

Table 62. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 63. Global Meningococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 64. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 65. Global Meningococcal Vaccine Sales Forecast by Application (2021-2026) & (K Dose)

Table 66. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 67. Global Meningococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 68. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 69. Novartis Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 70. Novartis Meningococcal Vaccine Product Offered

Table 71. Novartis Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 72. Novartis Main Business

Table 73. Novartis Latest Developments

Table 74. GSK Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 75. GSK Meningococcal Vaccine Product Offered

Table 76. GSK Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 77. GSK Main Business

Table 78. GSK Latest Developments

Table 79. Merck Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 80. Merck Meningococcal Vaccine Product Offered

Table 81. Merck Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 82. Merck Main Business

Table 83. Merck Latest Developments

Table 84. CSL Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 85. CSL Meningococcal Vaccine Product Offered

Table 86. CSL Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 87. CSL Main Business

Table 88. CSL Latest Developments

Table 89. Baxter Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 90. Baxter Meningococcal Vaccine Product Offered

Table 91. Baxter Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 92. Baxter Main Business

Table 93. Baxter Latest Developments

Table 94. JN International Medical Corporation Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 95. JN International Medical Corporation Meningococcal Vaccine Product Offered

Table 96. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 97. JN International Medical Corporation Main Business

Table 98. JN International Medical Corporation Latest Developments

Table 99. Serum Institute of India Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 100. Serum Institute of India Meningococcal Vaccine Product Offered

Table 101. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 102. Serum Institute of India Main Business

Table 103. Serum Institute of India Latest Developments

Table 104. Bio-Med Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 105. Bio-Med Meningococcal Vaccine Product Offered

Table 106. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 107. Bio-Med Main Business

Table 108. Bio-Med Latest Developments

Table 109. China National Biotec Group Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 110. China National Biotec Group Meningococcal Vaccine Product Offered

Table 111. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 112. China National Biotec Group Main Business

Table 113. China National Biotec Group Latest Developments

Table 114. Hualan Bio Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 115. Hualan Bio Meningococcal Vaccine Product Offered

Table 116. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 117. Hualan Bio Main Business

Table 118. Hualan Bio Latest Developments

Table 119. Walvax Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 120. Walvax Meningococcal Vaccine Product Offered

Table 121. Walvax Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 122. Walvax Main Business

Table 123. Walvax Latest Developments

Table 124. Zhifei Basic Information, Meningococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 125. Zhifei Meningococcal Vaccine Product Offered

Table 126. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 127. Zhifei Main Business

Table 128. Zhifei Latest Developments

List of Figures

Figure 1. Picture of Meningococcal Vaccine

Figure 2. Meningococcal Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Meningococcal Vaccine Sales Growth Rate 2016-2026 (K Dose)

Figure 7. Global Meningococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Meningococcal Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Quadrivalent

Figure 10. Product Picture of Bivalent

Figure 11. Product Picture of Others

Figure 12. Global Meningococcal Vaccine Sales Market Share by Type in 2020

Figure 13. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)

Figure 14. Meningococcal Vaccine Consumed in Pneumonia

Figure 15. Global Meningococcal Vaccine Market: Pneumonia (2016-2021) & (K Dose)

Figure 16. Meningococcal Vaccine Consumed in Meningitis

Figure 17. Global Meningococcal Vaccine Market: Meningitis (2016-2021) & (K Dose)

Figure 18. Meningococcal Vaccine Consumed in Bacteremia

Figure 19. Global Meningococcal Vaccine Market: Bacteremia (2016-2021) & (K Dose)

Figure 20. Meningococcal Vaccine Consumed in Others (Arthritis, Conjunctivitis, Urethritis)

Figure 21. Global Meningococcal Vaccine Market: Others (Arthritis, Conjunctivitis, Urethritis) (2016-2021) & (K Dose)

Figure 22. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)

Figure 23. Global Meningococcal Vaccine Revenue Market Share by Application in 2020

Figure 24. Global Meningococcal Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 25. Global Meningococcal Vaccine Revenue Market Share by Company in 2020

Figure 26. Global Meningococcal Vaccine Sales Market Share by Regions (2016-2021)

Figure 27. Global Meningococcal Vaccine Revenue Market Share by Region in 2020

Figure 28. Americas Meningococcal Vaccine Sales 2016-2021 (K Dose)

Figure 29. Americas Meningococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 30. APAC Meningococcal Vaccine Sales 2016-2021 (K Dose)

Figure 31. APAC Meningococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 32. Europe Meningococcal Vaccine Sales 2016-2021 (K Dose)

Figure 33. Europe Meningococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 34. Middle East & Africa Meningococcal Vaccine Sales 2016-2021 (K Dose)

Figure 35. Middle East & Africa Meningococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 36. Americas Meningococcal Vaccine Sales Market Share by Country in 2020

Figure 37. Americas Meningococcal Vaccine Revenue Market Share by Country in 2020

Figure 38. Americas Meningococcal Vaccine Sales Market Share by Type in 2020

Figure 39. Americas Meningococcal Vaccine Sales Market Share by Application in 2020

Figure 40. United States Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 41. Canada Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 42. Mexico Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 43. Brazil Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. APAC Meningococcal Vaccine Sales Market Share by Region in 2020

Figure 45. APAC Meningococcal Vaccine Revenue Market Share by Regions in 2020

Figure 46. APAC Meningococcal Vaccine Sales Market Share by Type in 2020

Figure 47. APAC Meningococcal Vaccine Sales Market Share by Application in 2020

Figure 48. China Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Japan Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 50. Korea Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 51. Southeast Asia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 52. India Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 53. Australia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. Europe Meningococcal Vaccine Sales Market Share by Country in 2020

Figure 55. Europe Meningococcal Vaccine Revenue Market Share by Country in 2020

Figure 56. Europe Meningococcal Vaccine Sales Market Share by Type in 2020

Figure 57. Europe Meningococcal Vaccine Sales Market Share by Application in 2020

Figure 58. Germany Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 59. France Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 60. UK Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 61. Italy Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 62. Russia Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country in 2020

Figure 64. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country in 2020

Figure 65. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type in 2020

Figure 66. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application in 2020

Figure 67. Egypt Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 68. South Africa Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 69. Israel Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 70. Turkey Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 71. GCC Country Meningococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles